Literature DB >> 11145659

Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors.

A Curti1, M Fogli, M Ratta, S Tura, R M Lemoli.   

Abstract

We studied cytokine-driven differentiation of primitive human CD34(+)HLA-DR(-) cells to myeloid dendritic cells (DC). Hemopoietic cells were grown in long-term cultures in the presence of various combinations of early acting cytokines such as FLT3-ligand (FLT3-L) and stem cell factor (SCF) and the differentiating growth factors GM-CSF and TNF-alpha. Two weeks of incubation with GM-CSF and TNF-alpha generated fully functional DC. However, clonogenic assays demonstrated that CFU-DC did not survive beyond 1 wk in liquid culture regardless of whether FLT3-L and/or SCF were added. FLT3-L or SCF alone did not support DC maturation. However, the combination of the two early acting cytokines allowed a 100-fold expansion of CFU-DC for >1 month. Phenotypic analysis demonstrated the differentiation of CD34(+)DR(-) cells into CD34(-)CD33(+)DR(+)CD14(+) cells, which were intermediate progenitors capable of differentiating into functionally active DC upon further incubation with GM-CSF and TNF-alpha. As expected, GM-CSF and TNF-alpha generated DC from committed CD34(+)DR(+) cells. However, only SCF, with or without FLT3-L, induced the expansion of DC precursors for >4 wk, as documented by secondary clonogenic assays. This demonstrates that although GM-CSF and TNF-alpha do not require additional cytokines to generate DC from primitive human CD34(+)DR(-) progenitor cells, they do force terminal differentiation of DC precursors. Conversely, FLT3-L and SCF do not directly affect DC differentiation, but instead sustain the long-term expansion of CFU-DC, which can be induced to produce mature DC by GM-CSF and TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145659     DOI: 10.4049/jimmunol.166.2.848

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells.

Authors:  Leonia Bozzacco; Haiqiang Yu; Henry A Zebroski; Jörn Dengjel; Haiteng Deng; Svetlana Mojsov; Ralph M Steinman
Journal:  J Proteome Res       Date:  2011-10-14       Impact factor: 4.466

2.  Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function.

Authors:  Donald Cheatem; Balaji B Ganesh; Eryn Gangi; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Clin Immunol       Date:  2009-01-25       Impact factor: 3.969

3.  GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis.

Authors:  Balaji B Ganesh; Donald M Cheatem; Jian Rong Sheng; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Int Immunol       Date:  2009-01-27       Impact factor: 4.823

4.  HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC.

Authors:  Leonia Bozzacco; Christine Trumpfheller; Yaoxing Huang; Maria Paula Longhi; Irina Shimeliovich; Joseph D Schauer; Chae Gyu Park; Ralph M Steinman
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

5.  Identification and quantitation of MHC class II-bound peptides from mouse spleen dendritic cells by immunoprecipitation and mass spectrometry analysis.

Authors:  Leonia Bozzacco; Haiqiang Yu
Journal:  Methods Mol Biol       Date:  2013

6.  Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells.

Authors:  Shuhong Han; Yichen Wang; Bei Wang; Ekta Patel; Starlyn Okada; Li-Jun Yang; Jan S Moreb; Lung-Ji Chang
Journal:  J Immune Based Ther Vaccines       Date:  2010-11-24

7.  High susceptibility of c-KIT+CD34+ precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model.

Authors:  Rieneke van de Ven; Sue Ellen Verbrugge; Anneke W Reurs; Hetty J Bontkes; Erik Hooijberg; Gerrit Jansen; Rik J Scheper; George L Scheffer; Tanja D de Gruijl
Journal:  Cancer Immunol Immunother       Date:  2011-03-24       Impact factor: 6.968

8.  Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells.

Authors:  Yui Harada; Yae Okada-Nakanishi; Yasuji Ueda; Shunichi Tsujitani; Satoru Saito; Terumi Fuji-Ogawa; Akihiro Iida; Mamoru Hasegawa; Tomohiko Ichikawa; Yoshikazu Yonemitsu
Journal:  Sci Rep       Date:  2011-11-29       Impact factor: 4.379

9.  Endogenous Fms-like tyrosine kinase-3 ligand levels are not altered in mice after a severe burn and infection.

Authors:  Julia K Bohannon; Weihua Cui; Tracy Toliver-Kinsky
Journal:  BMC Immunol       Date:  2009-08-28       Impact factor: 3.615

10.  Isolation, growth and identification of colony-forming cells with erythroid, myeloid, dendritic cell and NK-cell potential from human fetal liver.

Authors:  Marcus O Muench; David L Suskind; Alicia Bárcena
Journal:  Biol Proced Online       Date:  2002-06-11       Impact factor: 3.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.